Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia
- 1 July 1991
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (1) , S18-S24
- https://doi.org/10.1016/0002-9343(91)90052-y
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Expanded clinical evaluation of lovastatin (EXCEL) study: Design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemiaThe American Journal of Cardiology, 1990
- Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1990
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967